News of the first takers of the desperately awaited Pfizer-BioNTech coronavirus vaccine spurred some hope and excitement amid new lockdowns and spiraling infections in much of the US and the UK. But in Russia, one of the few countries already offering vaccines to a wider segment of the general public, the turnout in the first two weeks of “large-scale” vaccination has been less than enthusiastic.
A nanoparticle revealed the tiny impact of a single gas atom 
Was van Gogh’s ‘The Starry Night’ a flight of fancy or a real sky? 
This ‘living drug’ could change the course of autoimmune disease 
AI could turn scientific papers into research assistants 
A lifesaving medication is not behind the drop in U.S. overdose deaths 
Peek into hidden worlds revealed by the 2026 Nikon Small World contest 
World News in Brief: Russian attacks intensify, UN team tours West Bank, ‘unlawful’ elderly deaths 
Mothers get nearly eight times more paid leave than fathers – and women pay the price 
Nepal’s deadly glacier flood a ‘defining moment’ for the international community 
First human case of Shamonda virus reported in France as patient dies